2606780-38-3
Chemical Structure
Cdc7-IN-8
- CAS No.: 2606780-38-3
- Formula:C19H21N5O2
- Molecular Weight:351.40
IUPAC Name: (S)-8-(quinuclidin-2-yl)-2,4,5,6-tetrahydropyrazolo[4'',3'':3',4']cyclohepta[1',2':4,5]furo[3,2-d]pyrimidin-10(9H)-one
InChIKey: GQKMQWSLJVXSMV-AWEZNQCLSA-N
SMILES: O=C1C2=C(C3=C(O2)C4=CNN=C4CCC3)N=C(N1)[C@@H]5CC6CCN5CC6
Biological Activity: Cdc7-IN-8 is a potent inhibitor of Cdc7. Cdc7 is a serine/threonine kinase which activates MCM promotion by phosphorylating the microchromosome maintenance protein (MCM protein), an important element of the DNA replication initiator. Cdc7-IN-8 has the potential for the research of cancer diseases (extracted from patent WO2021032170A1, compound 1-1/1-2)[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cdc7-IN-8 | Cdc7-IN-8 is a potent inhibitor of Cdc7. Cdc7 is a serine/threonine kinase which activates MCM promotion by phosphorylating the microchromosome maintenance protein (MCM protein), an important element of the DNA replication initiator. Cdc7-IN-8 has the potential for the research of cancer diseases (extracted from patent WO2021032170A1, compound 1-1/1-2). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
